IFFNYSEIndustrial Organic ChemicalsFiscal year ends December 31
INTERNATIONAL FLAVORS & FRAGRANCES INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$90.96+0.28 (+0.31%)
Close on Oct 19, 2026
- Market cap
- $23.38B
- P/E (TTM)
- –
- Dividend yield
- 1.76%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
100.0%
282M of 255M shares
Institutional holders
751
112 new, 56 sold out
Net institutional buying
25M
In Q2 2026
Insider trades, 12 months
10 buys · 6 sales
Net bought $31.15M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Dodge & Cox | 35,047,387 | 13.70% | 13G (passive) amendment | Jun 30, 2025 |
| Haldor Foundation | 25,356,381 | 9.90% | 13G (passive) amendment | Dec 31, 2024 |
| Vanguard Capital Management | 18,842,232 | 7.37% | 13G (passive) | Mar 31, 2026 |
| BlackRock, Inc. | 17,980,322 | 7.00% | 13G (passive) amendment | Mar 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of IFF | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Dodge & Cox | 37,007,037 | 14.50% | $2.93B | +534,095 | 1.53% |
| Freemont Capital Pte Ltd | 25,356,381 | 9.94% | $2.01B | – | 40.99% |
| BlackRock, Inc. | 23,175,401 | 9.08% | $1.84B | +454,108 | 0.03% |
| First Eagle Investment Management, LLC | 18,819,396 | 7.38% | $1.49B | +9,504,726 | 1.24% |
| Vanguard Capital Management LLC | 16,255,207 | 6.37% | $1.29B | +16,982 | 0.03% |
| State Street Corp | 12,340,998 | 4.84% | $982.39M | +1,053,044 | 0.03% |
| Vanguard Portfolio Management LLC | 11,608,686 | 4.55% | $919.64M | −114,545 | 0.04% |
| Invesco Ltd. | 9,403,330 | 3.69% | $744.93M | +1,910,489 | 0.06% |
| Geode Capital Management, LLC | 6,812,731 | 2.67% | $537.58M | −144,460 | 0.03% |
| UBS Asset Management Americas Inc | 6,112,514 | 2.40% | $484.23M | −94,581 | 0.09% |
| First Pacific Advisors, LP | 5,455,081 | 2.14% | $432.15M | +45,156 | 5.34% |
| Icahn Carl C | 4,275,000 | 1.68% | $338.67M | – | 4.10% |
| Massachusetts Financial Services Co /Ma/ | 3,871,551 | 1.52% | $331.69M | +804,612 | 0.11% |
| State Farm Mutual Automobile Insurance Co | 3,821,419 | 1.50% | $302.73M | – | 0.21% |
| Eurizon Capital SGR S.p.A. | 3,226,394 | 1.26% | $254.34M | +1,081,714 | 0.68% |
| Ameriprise Financial Inc | 2,967,609 | 1.16% | $235.11M | +283,515 | 0.05% |
| Northern Trust Corp | 2,932,363 | 1.15% | $232.30M | +18,464 | 0.03% |
| Nykredit A/S | 2,815,771 | 1.10% | $223.07M | New | 0.70% |
| Continental Grain Co | 2,682,730 | 1.05% | $212.53M | +260,000 | 47.41% |
| Morgan Stanley | 2,678,783 | 1.05% | $212.21M | +101,055 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 751 | 282M | 100.0% | 112 / 295 | 230 / 56 | 36M | 11M |
| Q1 2026 | 704 | 257M | 100.0% | 91 / 283 | 203 / 81 | 45M | 14M |
| Q4 2025 | 708 | 256M | 100.0% | 120 / 235 | 237 / 100 | 30M | 17M |
| Q3 2025 | 705 | 244M | 95.5% | 103 / 250 | 252 / 82 | 26M | 24M |
| Q2 2025 | 689 | 242M | 94.7% | 83 / 258 | 245 / 103 | 20M | 17M |
| Q1 2025 | 718 | 239M | 93.6% | 76 / 253 | 265 / 103 | 16M | 14M |
| Q4 2024 | 759 | 238M | 93.3% | 96 / 229 | 318 / 112 | 43M | 37M |
| Q3 2024 | 787 | 232M | 91.0% | 89 / 290 | 275 / 67 | 34M | 16M |
| Q2 2024 | 770 | 236M | 92.5% | 100 / 246 | 294 / 60 | 17M | 23M |
| Q1 2024 | 740 | 243M | 95.2% | 88 / 250 | 280 / 105 | 33M | 28M |
| Q4 2023 | 764 | 238M | 93.1% | 119 / 228 | 305 / 86 | 29M | 27M |
| Q3 2023 | 740 | 236M | 92.6% | 101 / 278 | 246 / 113 | 52M | 20M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of IFF | Value | % of fund | As of |
|---|---|---|---|---|---|
| Dodge & Cox Stock Fund | 17,514,000 | 6.86% | $1.39B | 1.17% | Jun 30, 2026 |
| Dodge & Cox International Stock Fund | 7,740,800 | 3.03% | $613.23M | 0.91% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 7,700,590 | 3.02% | $610.04M | 0.03% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 6,615,642 | 2.59% | $524.09M | 0.03% | Jun 30, 2026 |
| First Eagle Global Fund | 6,578,172 | 2.58% | $521.12M | 0.69% | Jul 31, 2026 |
| iShares Core S&P 500 ETF | 3,511,244 | 1.38% | $278.16M | 0.03% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 3,277,275 | 1.28% | $249.24M | 0.03% | May 31, 2026 |
| FPA Crescent Fund | 3,163,067 | 1.24% | $250.58M | 2.01% | Jun 30, 2026 |
| State Street(R) Materials Select Sector SPDR(R) ETF | 2,789,986 | 1.09% | $221.02M | 2.71% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 2,781,911 | 1.09% | $220.38M | 0.12% | Jun 30, 2026 |
| Vanguard Mid-Cap Index Fund | 2,628,001 | 1.03% | $208.19M | 0.09% | Jun 30, 2026 |
| Washington Mutual Investors Fund | 2,550,137 | 1.00% | $202.02M | 0.09% | Jul 31, 2026 |
| Invesco S&P 500 Equal Weight ETF | 2,510,449 | 0.98% | $198.88M | 0.21% | Jul 31, 2026 |
| Dodge & Cox Global Stock Fund | 2,447,927 | 0.96% | $193.92M | 1.49% | Jun 30, 2026 |
| Invesco Comstock Fund | 2,304,949 | 0.90% | $182.60M | 1.22% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| J. Erik Fyrwald | Chief Executive Officer, Director | 120,966 | 0.05% | May 4, 2026 |
| de Mendonca Ana Paula Teles | President, Scent | 0 | – | Aug 19, 2026 |
| Marc Birenkrant | Controller & CAO | 9,643 | 0.00% | Aug 10, 2026 |
| Michael DeVeau | EVP, CFO | 5,199 | 0.00% | Aug 7, 2026 |
| Ralf Finzel | EVP, Global Operations Officer | 17,621 | 0.01% | May 6, 2026 |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 37,925 | 0.01% | May 6, 2026 |
| Yuvraj Arora | President, Taste & CCO | 17,283 | 0.01% | May 4, 2026 |
| Andres Roberto Muller | President, Food Ingredients | 3,016 | 0.00% | Apr 3, 2026 |
| Stephen N. Landsman | EVP, General Counsel | 17,164 | 0.01% | Apr 3, 2026 |
| Leticia Goncalves Lourenco | President, Health & Bioscience | 5,983 | 0.00% | Apr 3, 2026 |
| Beril Yildiz | CAO, SVP & Controller | 3,321 | 0.00% | May 19, 2025 |
| Angela Strzelecki | President, Pharma Solutions | 10,362 | 0.00% | Apr 7, 2025 |
| Jennifer Amy Johnson | EVP, General Counsel | 7,357 | 0.00% | Mar 6, 2025 |
| Simon Herriott | Pres. Health & Bioscience | 10,755 | 0.00% | Mar 6, 2025 |
| Paul J. Fribourg | Director | 2,726,339 | 1.07% | Jun 2, 2026 |
| Jesus B. Mantas | Director | – | – | May 5, 2026 |
| Cynthia T. Jamison | Director | 604 | 0.00% | May 5, 2026 |
| Dawn C. Willoughby | Director | 434 | 0.00% | May 5, 2026 |
| Brett Icahn | Director | 34,712 | 0.01% | May 4, 2026 |
| Virginia Drosos | Director | 2,434 | 0.00% | May 4, 2026 |
| Mehmood Khan | Director | 7,173 | 0.00% | May 4, 2026 |
| Richard Mulligan | Director | 1,712 | 0.00% | May 4, 2026 |
| Kevin O'Byrne | Director | 26,071 | 0.01% | May 4, 2026 |
| Mark J. Costa | Director | 463 | 0.00% | Mar 25, 2026 |
| Hernandez Margarita Palau | Director | 2,393 | 0.00% | May 20, 2025 |
| John Francis Ferraro | Director | – | – | May 5, 2025 |
| Vincent J. Intrieri | Director | 604 | 0.00% | May 5, 2025 |
| Kathryn Jean Boor | Director | 255 | 0.00% | May 5, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| de Mendonca Ana Paula Teles President, Scent | Aug 17, 2026 | Sale | −5,718 | $83.19 | $475.68K | 0 |
| Marc Birenkrant Controller & CAO | Aug 7, 2026 | Sale | −1,000 | $85.00 | $85.00K | 3,446 |
| Michael DeVeau EVP, CFO | Aug 6, 2026 | Sale | −8,825 | $85.55 | $754.98K | 5,199 |
| Paul J. Fribourg Director | Jun 1, 2026 | Buy | +260,000 | $74.28 | $19.31M | 2,682,730 |
| Paul J. Fribourg Director | Jun 1, 2026 | Buy | +13,500 | $74.49 | $1.01M | 43,150 |
| Marc Birenkrant Controller & CAO | May 4, 2026 | Tax withholding | −141 | $70.09 | $9.88K | 4,446 |
| Marc Birenkrant Controller & CAO | May 4, 2026 | Option exercise | +389 | – | – | 4,587 |
| Deborah Borg EVP, Chief Ppl&Culture Officer | May 4, 2026 | Tax withholding | −713 | $70.09 | $49.97K | 37,925 |
| Deborah Borg EVP, Chief Ppl&Culture Officer | May 4, 2026 | Option exercise | +1,768 | – | – | 38,638 |
| Michael DeVeau EVP, CFO | May 4, 2026 | Tax withholding | −452 | $70.09 | $31.68K | 14,024 |
| Michael DeVeau EVP, CFO | May 4, 2026 | Option exercise | +884 | – | – | 14,476 |
| Ralf Finzel EVP, Global Operations Officer | May 4, 2026 | Tax withholding | −734 | $70.09 | $51.45K | 17,621 |
| Ralf Finzel EVP, Global Operations Officer | May 4, 2026 | Option exercise | +1,326 | – | – | 18,355 |
| de Mendonca Ana Paula Teles President, Scent | May 4, 2026 | Tax withholding | −362 | $70.09 | $25.37K | 5,718 |
| de Mendonca Ana Paula Teles President, Scent | May 4, 2026 | Option exercise | +708 | – | – | 6,080 |
| Mehmood Khan Director | May 1, 2026 | Option exercise | +2,569 | – | – | 7,173 |
| Deborah Borg EVP, Chief Ppl&Culture Officer | May 1, 2026 | Option exercise | +2,381 | – | – | 37,830 |
| Deborah Borg EVP, Chief Ppl&Culture Officer | May 1, 2026 | Tax withholding | −960 | $70.81 | $67.98K | 36,870 |
| Richard Mulligan Director | May 1, 2026 | Option exercise | +1,712 | – | – | 1,712 |
| Kevin O'Byrne Director | May 1, 2026 | Tax withholding | −1,157 | $70.81 | $81.93K | 17,571 |
| Kevin O'Byrne Director | May 1, 2026 | Option exercise | +4,282 | – | – | 18,728 |
| Virginia Drosos Director | May 1, 2026 | Option exercise | +2,335 | – | – | 2,434 |
| de Mendonca Ana Paula Teles President, Scent | May 1, 2026 | Tax withholding | −625 | $70.81 | $44.26K | 5,372 |
| de Mendonca Ana Paula Teles President, Scent | May 1, 2026 | Option exercise | +1,587 | – | – | 5,997 |
| Yuvraj Arora President, Taste & CCO | May 1, 2026 | Tax withholding | −1,828 | $70.81 | $129.44K | 17,283 |
| Yuvraj Arora President, Taste & CCO | May 1, 2026 | Option exercise | +3,572 | – | – | 19,111 |
| Brett Icahn Director | May 1, 2026 | Option exercise | +1,712 | – | – | 34,712 |
| Michael DeVeau EVP, CFO | May 1, 2026 | Tax withholding | −710 | $70.81 | $50.28K | 13,592 |
| Michael DeVeau EVP, CFO | May 1, 2026 | Option exercise | +1,389 | – | – | 14,302 |
| Ralf Finzel EVP, Global Operations Officer | May 1, 2026 | Option exercise | +1,984 | – | – | 18,127 |
| Ralf Finzel EVP, Global Operations Officer | May 1, 2026 | Tax withholding | −1,098 | $70.81 | $77.75K | 17,029 |
| J. Erik Fyrwald Chief Executive Officer, Director | May 1, 2026 | Tax withholding | −7,763 | $70.81 | $549.70K | 109,676 |
| J. Erik Fyrwald Chief Executive Officer, Director | May 1, 2026 | Option exercise | +15,875 | – | – | 117,439 |
| Marc Birenkrant Controller & CAO | May 1, 2026 | Tax withholding | −144 | $70.81 | $10.20K | 4,198 |
| Marc Birenkrant Controller & CAO | May 1, 2026 | Option exercise | +397 | – | – | 4,342 |
| Leticia Goncalves Lourenco President, Health & Bioscience | Apr 1, 2026 | Tax withholding | −1,335 | $72.57 | $96.88K | 5,983 |
| Leticia Goncalves Lourenco President, Health & Bioscience | Apr 1, 2026 | Option exercise | +4,305 | – | – | 4,305 |
| Leticia Goncalves Lourenco President, Health & Bioscience | Apr 1, 2026 | Option exercise | +3,013 | – | – | 7,318 |
| Leticia Goncalves Lourenco President, Health & Bioscience | Apr 1, 2026 | Tax withholding | −1,908 | $72.57 | $138.46K | 4,075 |
| Ralf Finzel EVP, Global Operations Officer | Apr 1, 2026 | Tax withholding | −868 | $72.57 | $62.99K | 16,143 |
| Ralf Finzel EVP, Global Operations Officer | Apr 1, 2026 | Option exercise | +2,152 | – | – | 17,011 |
| de Mendonca Ana Paula Teles President, Scent | Apr 1, 2026 | Tax withholding | −932 | $72.57 | $67.64K | 4,410 |
| de Mendonca Ana Paula Teles President, Scent | Apr 1, 2026 | Option exercise | +2,583 | – | – | 5,342 |
| Deborah Borg EVP, Chief Ppl&Culture Officer | Apr 1, 2026 | Option exercise | +2,030 | – | – | 36,268 |
| Deborah Borg EVP, Chief Ppl&Culture Officer | Apr 1, 2026 | Tax withholding | −819 | $72.57 | $59.43K | 35,449 |
| Marc Birenkrant Controller & CAO | Apr 1, 2026 | Tax withholding | −171 | $72.57 | $12.41K | 3,945 |
| Marc Birenkrant Controller & CAO | Apr 1, 2026 | Option exercise | +473 | – | – | 4,116 |
| Yuvraj Arora President, Taste & CCO | Apr 1, 2026 | Option exercise | +4,305 | – | – | 17,742 |
| Yuvraj Arora President, Taste & CCO | Apr 1, 2026 | Tax withholding | −2,203 | $72.57 | $159.87K | 15,539 |
| Michael DeVeau EVP, CFO | Apr 1, 2026 | Tax withholding | −2,418 | $72.57 | $175.47K | 12,913 |
| Michael DeVeau EVP, CFO | Apr 1, 2026 | Option exercise | +4,735 | – | – | 15,331 |
| Andres Roberto Muller President, Food Ingredients | Apr 1, 2026 | Tax withholding | −759 | $72.57 | $55.08K | 3,016 |
| Andres Roberto Muller President, Food Ingredients | Apr 1, 2026 | Option exercise | +2,583 | – | – | 3,775 |
| Stephen N. Landsman EVP, General Counsel | Apr 1, 2026 | Tax withholding | −1,164 | $72.57 | $84.47K | 17,164 |
| Stephen N. Landsman EVP, General Counsel | Apr 1, 2026 | Option exercise | +3,228 | – | – | 18,328 |
| J. Erik Fyrwald Chief Executive Officer, Director | Apr 1, 2026 | Option exercise | +18,769 | – | – | 110,399 |
| J. Erik Fyrwald Chief Executive Officer, Director | Apr 1, 2026 | Tax withholding | −8,835 | $72.57 | $641.16K | 101,564 |
| J. Erik Fyrwald Chief Executive Officer, Director | Mar 13, 2026 | Buy | +13,360 | $69.85 | $933.20K | 91,630 |
| Paul J. Fribourg Director | Mar 12, 2026 | Buy | +14,200 | $70.07 | $994.99K | 29,650 |
| Paul J. Fribourg Director | Mar 12, 2026 | Buy | +142,000 | $70.13 | $9.96M | 2,422,730 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| de Mendonca Ana Paula Teles Officer | Aug 17, 2026 | 5,718 | $475.69K | Aug 17, 2026 | Restricted Stock Vesting |
| Marc Birenkrant Officer | Aug 7, 2026 | 1,000 | $85.00K | Aug 7, 2026 | Restricted Stock Vesting |
| Michael DeVeau Officer | Aug 6, 2026 | 8,825 | $754.97K | Aug 6, 2026 | Restricted Stock Vesting |
| Beril Yildiz Former Officer | Nov 7, 2025 | 4,060 | $253.81K | Nov 7, 2025 | Restricted Stock Vesting |
| Beril Yildiz Officer | May 19, 2025 | 2,400 | $185.60K | May 19, 2025 | Restricted Stock Vesting |
| Yuvraj Arora Officer | Nov 12, 2024 | 5,000 | $458.78K | Nov 11, 2024 | Restricted Stock Vesting |
| Angela Strzelecki Officer | Jun 13, 2024 | 2,588 | $247.56K | Jun 13, 2024 | Option Granted - 02/19/2020 |
| de Villeplee Christophe Fauchon Officer | May 11, 2023 | 1,972 | $170.28K | May 11, 2023 | Restricted Stock Units |